CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Curis (CRIS) Stock Fair Value Moves Lower After Emavusertib TakeAim Model Rework

EmavusertibNegative
AI Analysis

Summary

Curis (CRIS) stock fair value assessment has been lowered following a reworking of the TakeAim model for Emavusertib.

Outcome Details

TakeAim Model Rework

Importance:3/10
Sentiment:
-0.50
valuationemavusertibmodel_rework
Related Companies

Read the original article

Published by yahoo_finance on August 5, 2026 5:11 PM

Read Original